Related Experiment Videos
A single nucleotide polymorphism in the Mdm2 promoter and risk of sepsis
David A Kleiman1, Jacqueline E Calvano, Susette M Coyle
1Division of Surgical Sciences, Department of Surgery, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Background:
The Mdm2-SNP309(T/G) polymorphism has been shown to upregulate transcription of Mdm2 and subsequently attenuate the p53 pathway. Its role in regulating the human response to acute illness has not been reported.
Methods:
Patients from the surgical intensive care unit were prospectively enrolled. SNP309 genotype was determined, and a genotype-based comparison of clinical outcomes was performed.
Results:
Of the 85 enrolled patients, 41 had wild type (T/T) and 44 had mutant (32 T/G and 12 G/G) genotypes. The mutant-genotype group tended to have a longer LOS in both the surgical intensive care unit (P = .40) and the hospital (P = .08), but these trends did not reach significance. No observable genotype-based differences were noted in any other measured parameters.
Conclusions:
The Mdm2-SNP309(G) allele may be associated with longer LOS. However, it does not appear to influence any other clinical characteristics, nor can it be used to predict clinical outcome.
Insights
The Mdm2-SNP309(G) allele may be linked to longer hospital stays in critically ill patients. However, this genetic variation does not appear to affect other clinical outcomes or predict patient prognosis.
Area of Science:
- Genetics
- Molecular Biology
- Critical Care Medicine
Background:
- The Mdm2-SNP309(T/G) polymorphism influences Mdm2 gene transcription and the p53 pathway.
- The impact of this polymorphism on acute illness response in humans is not well-documented.
Purpose of the Study:
- To investigate the association between the Mdm2-SNP309 genotype and clinical outcomes in surgical intensive care unit patients.
- To determine if Mdm2-SNP309 genotype can predict clinical outcomes in acute illness.
Main Methods:
- Prospective enrollment of patients from a surgical intensive care unit.
- Determination of Mdm2-SNP309 genotype (T/T, T/G, G/G).
- Comparison of clinical outcomes based on genotype.
Main Results:
- Eighty-five patients were analyzed: 41 with wild-type (T/T) and 44 with mutant (T/G or G/G) genotypes.
- Patients with the mutant genotype showed a trend towards longer length of stay (LOS) in the ICU and hospital, though not statistically significant.
- No significant genotype-based differences were observed in other clinical parameters.
Conclusions:
- The Mdm2-SNP309(G) allele may be associated with an increased length of stay.
- This polymorphism does not appear to influence other clinical characteristics or serve as a predictor of clinical outcome in this patient cohort.
Related Concept Videos
Abnormal Proliferation
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Master Transcription Regulators
Single Nucleotide Polymorphisms-SNPs
Clinical Significance of Antibiotic Resistance